Cargando…

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator

AIMS: The implantable cardioverter-defibrillator (ICD) is a life-saving therapy in patients with hypertrophic cardiomyopathy (HCM) at risk of sudden cardiac death. Implantable cardioverter-defibrillator complications are of concern. The subcutaneous ICD (S-ICD) does not use transvenous leads and is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francia, Pietro, Ziacchi, Matteo, Adduci, Carmen, Ammendola, Ernesto, Pieragnoli, Paolo, De Filippo, Paolo, Rapacciuolo, Antonio, Rella, Valeria, Migliore, Federico, Viani, Stefano, Musumeci, Maria Beatrice, Biagini, Elena, Lovecchio, Mariolina, Baldini, Rossella, Falasconi, Giulio, Autore, Camillo, Biffi, Mauro, Cecchi, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507661/ https://www.ncbi.nlm.nih.gov/pubmed/37724686 http://dx.doi.org/10.1093/europace/euad270

Ejemplares similares

The “Defibrillation Testing, Why Not?” survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice()
por: Migliore, Federico, et al.
Publicado: (2022)

Modern subcutaneous implantable defibrillator therapy in patients with cardiomyopathies and channelopathies: data from a large multicentre registry
por: Migliore, Federico, et al.
Publicado: (2023)

Procedure, management, and outcome of subcutaneous implantable cardioverter–defibrillator extraction in clinical practice
por: De Filippo, Paolo, et al.
Publicado: (2023)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice
por: Rordorf, Roberto, et al.
Publicado: (2023)

Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case–control study
por: Botto, Giovanni Luca, et al.
Publicado: (2023)

Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current Knowledge
por: Musumeci, Beatrice, et al.
Publicado: (2021)

Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2023)

Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction
por: Russo, Vincenzo, et al.
Publicado: (2021)

Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator
por: Adduci, Carmen, et al.
Publicado: (2018)

Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators
por: Rella, Valeria, et al.
Publicado: (2020)

The natural history of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2020)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry
por: Russo, Vincenzo, et al.
Publicado: (2022)

Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study
por: Francia, P, et al.
Publicado: (2023)

Percutaneous Extraction of Transvenous Permanent Pacemaker/Defibrillator Leads
por: Paraskevaidis, Stylianos, et al.
Publicado: (2014)

Epicardial vs. transvenous implantable cardioverter defibrillators in children
por: Le Bos, Pierre Antoine, et al.
Publicado: (2023)

The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
por: Botto, Giovanni Luca, et al.
Publicado: (2017)

Left axillary active can positioning markedly reduces defibrillation threshold of a transvenous defibrillator failing to defibrillate at maximum output
por: Mitra, Raman L.
Publicado: (2018)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Forces Applied during Transvenous Implantable Cardioverter Defibrillator Lead Removal
por: Lennerz, Carsten, et al.
Publicado: (2014)

Transvenous Implantable Cardioverter-Defibrillator Lead Reliability: Implications for Postmarket Surveillance
por: Kramer, Daniel B, et al.
Publicado: (2015)

State‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy
por: Schukro, Christoph, et al.
Publicado: (2020)

Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome
por: Arcari, Luca, et al.
Publicado: (2021)

Outcomes after transvenous defibrillator implantation in cardiac sarcoidosis: A systematic review
por: Taha, Ahmed, et al.
Publicado: (2022)

Comparison of quality-of-life measures in patients with transvenous and subcutaneous implantable cardioverter-defibrillators
por: Ferrick, Aileen M., et al.
Publicado: (2023)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Usefulness of the MAGGIC Score in Predicting the Competing Risk of Non-Sudden Death in Heart Failure Patients Receiving an Implantable Cardioverter-Defibrillator: A Sub-Analysis of the OBSERVO-ICD Registry
por: Canepa, Marco, et al.
Publicado: (2021)

One-Year Follow-Up of Patients Undergoing Transvenous Extraction of Pacemaker and Defibrillator Leads
por: Kempa, Maciej, et al.
Publicado: (2015)

Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads
por: Koneru, Jayanthi N., et al.
Publicado: (2018)

Lead failure in transvenous implantable cardioverter defibrillator: a new opportunity for an effective management
por: Pignalberi, Carlo, et al.
Publicado: (2018)

Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients
por: Quast, A. B. E., et al.
Publicado: (2018)

Transvenous shock‐only implantable cardioverter defibrillator after an atrio‐pulmonary Fontan surgery
por: Toyohara, Keiko, et al.
Publicado: (2020)

A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort
por: Rubattu, Speranza, et al.
Publicado: (2016)

Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy
por: Cecconi, Massimiliano, et al.
Publicado: (2016)

Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies
por: Providência, Rui, et al.
Publicado: (2015)

A real‐world experience of subcutaneous and transvenous implantable cardiac defibrillators—comparison with the PRAETORIAN study
por: Khanra, Dibbendhu, et al.
Publicado: (2022)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
por: Kattih, Badder, et al.
Publicado: (2022)

Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database
por: Boriani, Giuseppe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_beg2qqo2js7dvnp8eqakfeg5ah